| 000 | 01882 a2200469 4500 | ||
|---|---|---|---|
| 005 | 20250517125512.0 | ||
| 264 | 0 | _c20180305 | |
| 008 | 201803s 0 0 eng d | ||
| 022 | _a1557-3265 | ||
| 024 | 7 |
_a10.1158/1078-0432.CCR-16-0869 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aMiller, Miles A | |
| 245 | 0 | 0 |
_aMolecular Pathways: Receptor Ectodomain Shedding in Treatment, Resistance, and Monitoring of Cancer. _h[electronic resource] |
| 260 |
_bClinical cancer research : an official journal of the American Association for Cancer Research _cFeb 2017 |
||
| 300 |
_a623-629 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Review | ||
| 650 | 0 | 4 |
_aADAM10 Protein _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aADAM17 Protein _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aAntineoplastic Agents _xmetabolism |
| 650 | 0 | 4 |
_aBody Fluids _xchemistry |
| 650 | 0 | 4 | _aDrug Design |
| 650 | 0 | 4 |
_aDrug Resistance, Neoplasm _xphysiology |
| 650 | 0 | 4 | _aEnzyme Activation |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aImmunotherapy |
| 650 | 0 | 4 |
_aMacrophages _xmetabolism |
| 650 | 0 | 4 | _aMolecular Targeted Therapy |
| 650 | 0 | 4 |
_aNeoplasm Proteins _xanalysis |
| 650 | 0 | 4 |
_aNeoplasms _xdrug therapy |
| 650 | 0 | 4 |
_aPeptide Fragments _xanalysis |
| 650 | 0 | 4 | _aProtein Domains |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProteolysis _xdrug effects |
| 650 | 0 | 4 |
_aReceptors, Cell Surface _xmetabolism |
| 650 | 0 | 4 | _aSubstrate Specificity |
| 650 | 0 | 4 |
_aTissue Inhibitor of Metalloproteinases _xphysiology |
| 650 | 0 | 4 | _aTumor Microenvironment |
| 700 | 1 | _aSullivan, Ryan J | |
| 700 | 1 | _aLauffenburger, Douglas A | |
| 773 | 0 |
_tClinical cancer research : an official journal of the American Association for Cancer Research _gvol. 23 _gno. 3 _gp. 623-629 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1158/1078-0432.CCR-16-0869 _zAvailable from publisher's website |
| 999 |
_c26646956 _d26646956 |
||